138 related articles for article (PubMed ID: 21440768)
1. Hyperuricemia after renal transplantation.
Kalantar E; Khalili N; Hossieni MS; Rostami Z; Einollahi B
Transplant Proc; 2011 Mar; 43(2):584-5. PubMed ID: 21440768
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
Akalin E; Ganeshan SV; Winston J; Muntner P
Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
[TBL] [Abstract][Full Text] [Related]
3. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
[TBL] [Abstract][Full Text] [Related]
4. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
Einollahi B; Einollahi H; Rostami Z
Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
[TBL] [Abstract][Full Text] [Related]
5. Hyperuricemia in kidney transplant recipients with intact graft function.
Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of early-onset hyperuricemia in renal transplant recipients.
Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW
Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570
[TBL] [Abstract][Full Text] [Related]
7. Anemia after kidney transplantation in adult recipients: prevalence and risk factors.
Einollahi B; Lessan-Pezeshki M; Rostami Z; Kalantar E; Afshar R; Beiraghdar F
Transplant Proc; 2011 Mar; 43(2):578-80. PubMed ID: 21440766
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T
Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291
[TBL] [Abstract][Full Text] [Related]
9. Uric acid and transplantation.
Mazali FC; Mazzali M
Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
[TBL] [Abstract][Full Text] [Related]
10. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
14. Role of uric acid in post-renal transplantation hypertension.
Bandukwala F; Huang M; Prasad GV
Transplant Proc; 2009 Jun; 41(5):1634-6. PubMed ID: 19545696
[TBL] [Abstract][Full Text] [Related]
15. Analysis of vascular complications after renal transplantation.
Aktas S; Boyvat F; Sevmis S; Moray G; Karakayali H; Haberal M
Transplant Proc; 2011 Mar; 43(2):557-61. PubMed ID: 21440760
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Hyperuricemia after Kidney Transplantation: Association with Graft Function.
Folkmane I; Tzivian L; Folkmane E; Valdmane E; Kuzema V; Petersons A
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32106421
[TBL] [Abstract][Full Text] [Related]
17. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
18. The independent association between serum uric acid and graft outcomes after kidney transplantation.
Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction.
Zlotnick DM; Axelrod DA; Chobanian MC; Friedman S; Brown J; Catherwood E; Costa SP
Nephrol Dial Transplant; 2010 Sep; 25(9):3090-6. PubMed ID: 20299337
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia influences chronic cyclosporine nephropathy.
Saglam F; Celik A; Sarioglu S; Cavdar C; Sifil A; Gulay H; Camsari T
Transplant Proc; 2008; 40(1):167-70. PubMed ID: 18261576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
